Aqueous extract of rose hip has been found to inhibit the activation of NF-κB mediated by RANKL and slow down the RANKL-induced osteoclastogenesis, and hence it could constitute a bioactive molecule against bone destruction in RA [119]. The gene discussed is TNFSF11; the disease is rheumatoid arthritis.